This is a multicenter, randomized, open label phase lll trial to assess whether preoperative chemotherapy, as an adjunct to curative-intent surgery, improves the prognosis of high risk DDLPS (dedifferentiated Liposarcoma) and LMS (Leiomyosarcoma)…
- Investigator
- Leighton A Elliott
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All